Concepedia

Andrew M. Anisfeld

AM

7

Publications

2K

Citations

7

H-Index

2001

Active since

Affiliations

University of California, Los Angeles(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United States)

Howard Hughes Medical Institute

Andrew M. Anisfeld is an author at University of California, Los Angeles specializing in biochemistry, natural sciences, and molecular biology.

Top concepts

Publications per year

2001–2004

7

Publications

7

Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor

Heidi R. Kast-Woelbern, Bryan Goodwin, Paul T. Tarr et al. · Journal of Biological Chemistry · 2002 · 903 citations · Full text

BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis

Peter A. Edwards, Heidi R. Kast-Woelbern, Andrew M. Anisfeld · Journal of Lipid Research · 2002 · 384 citations · Full text

A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR

Michael Downes, Mark A. Verdecia, Anthony J. Roecker et al. · Molecular Cell · 2003 · 379 citations · Full text

, , +7

Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors

Puiying A. Mak, Heidi R. Kast-Woelbern, Andrew M. Anisfeld et al. · Journal of Lipid Research · 2002 · 123 citations · Full text

Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor

Andrew M. Anisfeld, Heidi R. Kast-Woelbern, Marie E. Meyer et al. · Journal of Biological Chemistry · 2003 · 87 citations · Full text

Rows per page

1–5 of 7